康泰醫學(300869.SZ)榮獲2019年河北省政府質量獎
格隆匯 12 月 10日丨康泰醫學(300869.SZ)公佈,近日,公司收到河北省人民政府印發的《河北省人民政府關於2019年河北省政府質量獎授獎的決定》(冀政字[2020]57號)文件,公司榮獲“2019年河北省人民政府質量獎”。
“河北省政府質量獎”是河北省人民政府設立的最高質量榮譽獎項,授予在河北省行政區域內登記註冊,質量管理業績顯著,產品(工程、服務等)質量水平以及自主創新能力、管理水平在國內同行業處於領先地位,對河北省經濟社會發展作出積極貢獻的單位。
公司獲此榮譽,體現出河北省人民政府對公司的產品質量管理模式、推進質量管理創新、樹立質量標杆所取得成績的充分肯定。公司將以此作為新的起點,通過持續深入質量管理,不斷創新質量管理工作的方法,進一步提升公司產品質量和自主創新能力,增強公司核心競爭力,促進公司持續、健康、快速發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.